Ionis Pharmaceuticals, Inc.
SELECTIVE ANTISENSE COMPOUNDS AND USES THEREOF

Last updated:

Abstract:

The present disclosure provides oligomeric compounds. Certain such oligomeric compounds are useful for hybridizing to a complementary nucleic acid, including but not limited, to nucleic acids in a cell. In certain embodiments, hybridization results in modulation of the amount activity or expression of the target nucleic acid in a cell. In certain embodiments, certain oligomeric compounds selectively reduce the expression of a target nucleic acid transcript relative to a non-target nucleic acid transcript.

Status:
Application
Type:

Utility

Filling date:

29 Mar 2019

Issue date:

20 Feb 2020